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Summary
An assay has been developed in which the activity of an ubiquinol oxidase from Escherichia coli,
cytochrome bo3 (cbo3), is determined as a function of the hydrophobic substrate ubiquinol-10
(UQ-10) in tethered lipid bilayers membranes (tBLMs). UQ-10 was added in situ, while the
enzyme activity and the UQ-10 concentration in the membrane have been determined by cyclic
voltammetry. Cbo3 is inhibited by UQ-10 at concentrations above 5-10 pmol/cm2, while product
inhibition is absent. Cyclic voltammetry has also been used to characterise the effects of three
inhibitors; Cyanide, inhibiting oxygen reduction; 2-n-Heptyl-4-hydroxyquinoline N-oxide
(HQNO), inhibiting the quinone oxidation and Zn(II), thought to block the proton channels
required for oxygen reduction and proton pumping activity. The electrochemical behaviour of
cbo3 inhibited with HQNO and Zn(II) is almost identical, suggesting that Zn(II) ions inhibit the
enzyme reduction by quinol, rather than oxygen reduction. This suggests that at Zn(II)
concentration below 50 μM the proton release of cbo3 is inhibited, but not the proton uptake
required to reduce oxygen to water.
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Introduction
Bacteria have highly diverse and highly branched respiratory chains [1] which consist of a
range of enzymes which transfer electrons from many different substrates into a common
pool of lipid soluble electron carriers, known collectively as quinones. There are a number
of different quinones expressed in organisms including ubiquinone or coenzyme Q,
menaquinone and plastoquinone. The composition of the quinone pool in the membrane is
dependent on the species and growth conditions. Generally, anaerobic and gram positive
bacteria tend to use menaquinones whereas aerobic gram negative bacteria and eukaryotic
membranes are predominantly composed of ubiquinones.[2] Ubiquinone-8 is the
predominant electron carrier in aerobically grown Escherichia coli.
In the E. coli aerobic respiratory pathway there are two terminal oxidases that catalyse the
oxidation of ubiquinol to ubiquinone and reduce molecular oxygen to water. Expression of
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cytochrome bo3 (cbo3) is the favoured terminal oxidase under high oxygen conditions and
cytochrome bd is expressed under microaerophilic conditions.[3, 4] Cbo3 is of particular
interest as it is structurally related to the eukaryotic cytochrome c oxidase.[5] In the catalytic
cycle of cbo3, ½O2 is reduced to H2O for every ubiquinol that is oxidised and a total of four
protons are translocated across the membrane, two of which come from the oxidation of
ubiquinol and reduction of ½O2. The remaining two are pumped through the protein in
conjunction with the catalytic cycle.[6] Cbo3 contains two ubiquinol binding sites, a low
affinity site (QL), which binds the substrate ubiquinol for catalysis and is in equilibrium with
the free ubiquinone pool in the membrane, and a high affinity site (QH), which stabilises the
semiquinone intermediate during catalysis and is not exchanged with the the UQ pool in the
bilayer.[7] When the crystal structure of cbo3 was solved, no quinone was found in the QH
but the structure enabled the authors to suggest a binding pocket.[5] This site was later
confirmed and further refined by mutagenenis and labelling studies in the group of Gennis.
[8-10]
The characterisation of transmembrane redox enzymes can be problematic due to the
atypical nature of their substrates. Analysis of enzyme kinetics with hydrophobic substrates
can be complicated by incomplete knowledge of the true substrate concentration in the
membrane.[11] Long chain quinones such as UQ-10 are extremely hydrophobic and rapidly
aggregate in aqueous solution, so water soluble substrate analogues such as UQ-1, UQ-2 and
duroquinol are commonly used to derive kinetic and mechanistic information. We have
developed a membrane model in which the activity of cbo3 can be assayed under near native
conditions in a tethered bilayer lipid membrane (tBLM, Figure 1).[12, 13] tBLMs are
biomimetic surfaces that were first designed in the 90ies as a model membrane system to
study a wide variety of membrane properties, ranging from the physical chemistry of lipid
membranes, ion transport through ion channels to enzyme kinetics of membrane-bound
oxidoreductases.[14-16]
The general principle of a tBLM is based on a surface that is modified with synthetic lipids,
which consist of a lipid headgroup, a linker moiety and a group that binds to the surface. In
our system the lipid headgroup is a cholesterol, the linker consist of three repeats of
ethyleneglycol and the surface-binding group is a thiol (Figure 1, top). When these modified
surfaces are incubated with lipid vesicles, the vesicles spread onto the modified surfaces and
cover the synthetic lipids with phospholipid layer and thus creating a bilayer. In our system,
the coverage of the synthetic cholesterol linker is reduced by mixing it with 6-
mercaptohexanol. Because the two thiol molecules phase separate on the gold surface,
cholesterol-free regions are created with space for integral membrane proteins (Figure 1,
bottom).[17] A particularly important feature of this membrane model is that the native,
hydrophobic quinones can be incorporated in the bilayer.
We have previously shown that tBLMs can be used to study the enzyme kinetics of quinone
converting enzymes like cbo3 using voltammetric methods.[13, 18, 19] In this method,
ubiquinone in the tBLM is electrochemically reduced by the electrode and after diffusion to
cbo3 ubiquinol is catalytically oxidised, creating a redox loop. By measuring the electron
consumption at the surface (the electrode current), the enzyme activity is thus established. In
the past we have incorporated cbo3 by assembling the tBLM with proteoliposomes that were
prepared with purified enzyme.[18] More recently, we have prepared tBLMs from total
inner membrane extract from E. coli.[13, 19] The advantage of latter system is that no
complex or harsh purification procedures are used and that the protein of interest is
permanently retained within its natural membrane environment.
We have continued this previous work by developing an assay to determine enzymes
kinetics as a function of UQ-10 concentration in the membrane. By adding UQ-10 in situ,
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higher concentration of UQ-10 can be reached than we reported previously.[13] We have
also carried out inhibition studies to interpret and understand mechanisms and behaviour of
quinone converting enzymes. We present voltammetric evidence of different modes of
inhibition from three distinct inhibitors which are known to bind and to different sites of
cbo3.
Materials and Methods
Materials
EO3-cholesteryl was made as previously described[20]. 6-Mercaptohexanol (Fluka) was
used without further purification. All solvents were HPLC grade (Fisher) and used as
received. 20 mM MOPS buffer with 30 mM Na2SO4 adjusted to pH 7.4 was used for the
preparation of membrane extracts and all electrochemistry experiments. For inhibition
studies, ubiquinone-10 (Sigma) was made up as 1mg/ml stock solution in chloroform and
stored at −20° C. E. coli polar extract (Avanti) was stored in 5 mg dry aliquots stored under
nitrogen at −20° C. NaCN and ZnSO4 were added from a aqueous stock solution of 5 and
10mM, respectively. 2-n-Heptyl-4-hydroxyquinoline N-oxide (HQNO, Alexis biochemicals)
was made up as a stock solution of 20mM in methanol and stored at −20° C. For in situ
titration of UQ-10, UQ-10 was made up as stock solutions of 500nM, 5μM, 50μM, 500μM
and 5mM in dimethyl sulfoxide (DMSO).
E. coli inner membrane purification
E. coli inner membranes were prepared from strain GO105/pJRhisA in which the cbo3
protein is overexpressed and no cytochrome bd is present[21]. E. coli was grown to mid-log
phase at 37° C with shaking in LB medium supplemented with 500 μM CuSO4 and 100
μg/ml carbenicillin. E. coli cells were harvested from the growth medium by centrifugation
at 12000 g for 30 minutes and cell paste was frozen at −20° C overnight. Thawed E. coli cell
paste was resuspended in 20 mM MOPS 30mM Na2SO4 buffer at approximately 30 mL
buffer per 10 g cell paste and passed through a cell disrupter two times at 35000 psi. Cell
debris was removed by centrifugation at 12000 g for 30 minutes. The supernatant containing
the membrane fraction was centrifuged at 131000 g for 2 hours and the membrane pellet was
resuspended in 25% w/w sucrose-MOPS/Na2SO4 buffer. A 30% w/w to 55% w/w sucrose
gradient with centrifugation at 131000 g for 16 hours with no deceleration or breaking was
used to separate the inner membrane from the outer membrane. The inner membrane
fraction was removed from the sucrose gradient and washed several times with buffer by
centrifugation at 131000 g for 2 hours. The protein concentration of the inner membrane
preparation was determined using a Schaffner-Weissman assay[22]. Inner membrane
vesicles were resuspended in buffer and stored in 5 mg/ml protein aliquots at −80° C.
Mixed Vesicle Preparation
For the inhibition studies 1% w/w ubiquinol-10 solution was added to E. coli polar extract
lipids and dried under nitrogen to form a multilammelar film on the sides of a glass vial. The
lipid/UQ-10 film was resuspended in buffer (5 mg/ml) by vortexing. Lipid vesicles were
formed by extrusion through a track etched membrane (200nm, Avanti), mixed with inner
membrane vesicles (10% v/v) and subjected to three rounds of freeze-thawing before
passing through a track etched membrane another 11 times. For membranes used in the in
situ UQ-10 titration, mixed vesicles were prepared as described but no UQ-10 was added to
the E. coli polar extract lipids.
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Electrodes and tethered membrane formation
Template-stripped gold (TSG) surfaces were formed as previously described[23]. Briefly,
150 nm of gold was evaporated onto a clean, polished silicon wafer. 12 mm by 12 mm clean
glass microscope slides were glued to the gold surface using Epo-tek 377 and cured for 2
hours at 120° C. Once cooled, the glass slides could be removed from the silicon wafer to
expose the template-stripped gold surface ready for the formation of the self-assembled
monolayer (SAM).
SAMs were formed by incubating a freshly exposed TSG slide in 0.11 mM EO3-cholesteryl
and 0.89 mM 6-mercaptohexanol in propanol for 16 hours. This forms a 60%/40% EO3-
cholesteryl/6-mercaptohexanol area ratio on the surface which was checked with impedance
spectroscopy before each experiment[17]. The slides were rinsed with propanol and
methanol and dried under nitrogen before being incorporated into the electrochemical cell.
To form tethered bilayer lipid membranes (tBLMs), mixed vesicles were added to the SAM
surface at a final concentration of 0.5 mg/ml in the presence of 10 mM CaCl2 and incubated
for 2 hours. The surface was then rinsed several times with buffer and 1 mM EDTA to
remove any traces of calcium ions in the cell.
Electrochemistry
Electrochemical measurements were carried out in a glass electrochemical cell which holds
2 mL of buffer and was thermostatted at 20° C. A saturated calomel electrode (SCE) or
saturated Ag/AgCl reference electrode was used as the reference electrode (Radiometer
Analytical) and a platinum wire was used as the counter electrode. All potentials are quoted
versus the Standard Hydrogen Electrode (SHE). The gold-SAM working electrode was
secured at the open base of the electrochemical cell in a PTFE electrode holder, exposing an
electrode area of 0.25 cm2. The electrochemical cell was housed in a Faraday cage to
minimise electrical noise and argon was used to purge the cell of oxygen. For the in situ
UQ-10 titration, the experimental apparatus was stored and assembled inside a nitrogen
filled glovebox (MBraun MB 150 B-G) where the O2 levels were <1 ppm and air
equilibrated buffer was added to the electrochemical cell to give an oxygen concentration of
100 μM, well in excess of the KM. Electrochemical measurements were recorded using an
Autolab (Ecochemie) electrochemical analyser with a PGSTAT30 potentiostat and a FRA2
frequency analyser. All cyclic voltammetry experiments were carried out by holding the
potential at 0.4 V for 5 seconds and cycling to −0.4 V and back at a scan rate of 0.01 V/s.
For the in situ UQ-10 titration, the UQ-10 concentration within the bilayer was monitored
using cyclic voltammetry at 1V/s scan rate. At this high scan rate, the catalytic activity of
the enzyme in the tBLM is outrun and a clear peak is observed due to the UQ-10 reduction.
The area underneath the peak, determined by the software ‘Utils’, kindly provided by Dr.
H.A. Heering, was used to calculate the UQ-10 concentration in the tBLM.
For analysis of the inhibition data, the baseline of the CV was determined from the fully
inhibited trace (using the ‘Utils’ software) and subsequently subtracted from all traces. To
determine the IC50 values, the relative current at −0.35V vs SHE was taken from the
baseline corrected data, although no significant difference was observed between IC50
values determined using baseline corrected data and the raw data.
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Results
In situ titration of UQ-10
Several organic solvents were tried to titrate UQ-10 in the electrochemical cell, including
ethanol and acetone. DMSO was found to be the most suitable solvent for in situ addition as
UQ-10 is soluble in DMSO up to concentrations of 5 mM, DMSO easily mixes with water
and is non-volatile. The main drawback is that DMSO has been suggested to disrupt and
permeablise cell membranes.[24] However, we did not observe and significant disruption to
the tBLM (only a small decrease in double layer capacitance was observed between 0 and
40% DMSO). Finally, no difference in the cbo3 activity was observed with cyclic
voltammetry when adding small amounts of DMSO (< 2%).
Figure 2a shows cyclic voltammograms (10 mV/s) of the tBLM at increasing amounts of
UQ-10. DMSO content stayed below 10% (v/v) throughout the titration. As is clear from
Figure 2a, the UQ-10 addition significantly changes the shape of the cyclic voltammograms.
At low concentration, the shape remains largely unchanged, but the current increases. At
high concentration, the wave converts into a peak shaped voltammogram, with the current at
low potential (< −0.3 V vs SHE) decreasing. The peak is partly due to large amount of
UQ-10 in the membrane, thus becoming more prominent relative to the catalytic wave.
Analysis of the peak area presented in the Discussion section shows that this peak signal
cannot be explained by UQ-10 reduction alone.
The reduction in current at low potential indicates that cbo3 is inhibited by UQ-10, a
property we could only tentatively conclude previously due to scatter in the data[13], but is
unambiguous from the in situ titrations with UQ-10. Finally, Figure 2a shows that the onset
of the wave occurs at higher potential when the UQ-10 concentration is increased. This is
not due to the DMSO, as no change in the CV is seen upon addition of DMSO alone. The
reason for this shift is explained in the Discussion section.
Using fast-scan voltammetry, the relationship between the concentration of UQ-10 in the
electrolyte and the concentration determined in the bilayer can be determined. At 1 V/s, the
voltammogram outruns catalysis and even at low UQ-10 concentrations, the wave
transforms to a peak corresponding to the UQ-10 reduction in the membrane. The area under
the peak is used to determine the UQ-10 coverage and the relation between UQ-10 added to
the electrolyte (in DMSO) and QU-10 incorporation in the membrane is shown in the insert
of Figure 2a. This relation is approximately linear, although the slope varies between
experiments. The quinone content in the membrane determined at 1 V/s is observed to be
lower than that at 10 mV/s (after inhibition of the enzyme with NaCN). Approximately 50%
of the UQ-10 signal is lost when the scan rate is increased from 10 mV/s to 1 V/s.
Previously, we have reported that the diffusion of UQ-10 across the tethered membrane is
slow with a ‘flip’ time between 0.05 and 1 s−1.[12] We thus assume that the loss of signal in
the fast-scan voltammetry is due to the diffusion kinetics of the UQ-10 in the membrane.
The relative activity of cbo3 with different UQ-10 concentrations in a tBLM at −0.35 V vs
SHE on the reverse scan of the CV is shown in Figure 2b (filled symbols). Correcting for the
loss in apparent UQ-10 coverage between 10 mV/s and 1 V/s, the data fits alongside data we
reported previously[13], in which UQ-10 was added to the lipid vesicles prior to tBLM
formation. In this latter approach, the UQ-10 content of the membrane was determined at 10
mV/s after inhibiting the enzyme with NaCN.
Inhibition of cbo3
Besides the in situ titration of UQ-10, the interaction between UQ-10 and cbo3 has also been
studied using inhibitors. Note that the cyclic voltammogram contains direct information
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about this interaction, as at each potential the enzyme activity (or current) is related to the
quinol/quinone ratio, which, when using slow scan rates, is in equilibrium throughout the
scan.
Cyanide is a well known and potent inhibitor of heme-copper oxidases. It binds to the
binuclear centre in cbo3 and prevents the reduction of oxygen to water. Figure 3, middle,
shows the forward part of the CVs collected after addition of NaCN. With increasing NaCN
concentration the size of the catalytic UQ wave decreases in magnitude and then transforms
to a peak shape. Closer examination reveals that the addition of NaCN reduces the
maximum current without changing the onset of the wave. This results in a shift of the
midpoint of the wave, which is more clearly visible in the first derivative shown at the
bottom of Figure 3. This behaviour is identical (albeit reversed) to the behaviour we have
previously indentified when activating anaerobic membrane samples with increasing oxygen
substrate concentrations[13], consistent with the fact the cyanide inhibits oxygen reduction.
At high concentrations (>50 μM) of NaCN, the enzyme is completely inhibited and no
further reduction of the peak is observed. The IC50 of NaCN with cbo3 in the native-like
tBLM is 7.96 ± 0.27 μM.
Cbo3 was also studied with the substrate analogue 2-n-Heptyl-4-hydroxyquinoline N-oxide
(HQNO), which is a napthoquinone analogue of the semiquinone intermediate. As with the
NaCN data, a transition is observed from wave to peak upon increasing HQNO
concentration. However, in contrast to NaCN, the midpoints of the wave remain unaltered.
In the baseline corrected voltammograms, an interesting double wave feature becomes
apparent at high HQNO concentration, which is due to the superposition of the quinol
reduction peak and the catalytic wave of reduced magnitude. As with NaCN we find that
HQNO can completely and fully inhibit the enzyme. The IC50 for HQNO is 28.7 ± 2.1 μM.
Zinc is known to be an inhibitor of a wide variety of bioenergetic enzymes including
cytochrome c oxidase[25, 26], mitochondrial complex I[27] and cbo3[3]. As with the
HQNO, the voltammograms for partially inhibited cbo3 shows that the midpoint of the wave
remains unaltered, ultimately resulting in the double wave feature. The IC50 for cbo3 with
ZnSO4 is 20.6 ± 3.6 μM. We note that the inhibition with ZnSO4 showed some variability in
the results, suggesting that the detailed structural properties of the tBLM influences the
Zn(II) enzyme interaction.
Discussion
Substrate inhibition
Quinones are hydrophobic electron carriers and an essential component of respiratory chains
in all organisms to mediate electron transfer between individual protein complexes. A
significant problem in being able to fully understand and interpret the roles of quinones in
biological processes is the lack of appropriate, physiologically relevant assays available.
Currently, the most widespread methods are spectrophotometric assays using short, water
soluble quinone analogues as long chain hydrophobic quinones can aggregate and form
micelles which increase the turbidity of the assay solution and interfere with accurate
measurements[28]. Another issue is the determination of accurate and absolute quinone
concentrations partitioned into the cell membrane. By using model bilayers tethered to an
electrode the activity of quinones with transmembrane enzymes can be easily and quickly
monitored[29]. With this approach quinone concentrations within the bilayer may be rapidly
and accurately determined using fast scan voltammetric methods and the quinone
concentration can be changed in situ by the addition of ubiquinone solubilised in DMSO.
The in situ UQ-10 addition data presented here corroborates our previously published data in
that cbo3 is inhibited by UQ-10. The shape of the voltammogram at high UQ-10 content
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(apparent coverage of 23 pmol/cm2 at 1 V/s corresponds to ~46 pmol/cm2 at 10 mV/s,
Figure 2a) shows a peak shape upon lowering the potential in which the area underneath the
peak far exceeds the quinone content of membrane. This behaviour can be explained by
assuming substrate inhibition, but not product inhibition. At high potential all UQ-10 is
oxidised, thus not inhibiting cbo3. In the initial stages of the catalytic wave, some UQ-10 is
reduced and substrate generated, but not yet to an extent that the enzyme is inhibited. Upon
reducing the potential further, more substrate is generated, inhibiting the enzyme and
thereby reducing the current, resulting in a peak shaped voltammogram. Besides the
catalytic wave, this peak shape is further enhanced by the large amount of UQ-10 in the
membrane as this induces a UQ-10 reduction peak in itself. Modelling studies shown in the
supporting information support this hypothesis. When both the product and the substrate
inhibits cbo3, the modelling shows the expected behaviour that the area underneath the peak
is equal or less than the UQ-10 coverage, in contrast with our data in which the area is larger
than the UQ-10 coverage. However, when only substrate inhibits cbo3 the model indicates
that the peak area can exceed that of the UQ-10 coverage.
The modelling studies also confirm that by increasing the UQ-10 in the tBLM, the onset of
the catalytic wave shifts to more positive potentials. The reason for this is complex, but can
approximately be explained by noting that at a given potential, a similar fraction of UQ-10
is in its reduced state. At higher coverage of UQ-10, this will lead to larger substrate
concentration and thus a higher turn-over of the enzyme.
Substrate inhibition (without product inhibition) has been observed previously by Musser et
al. [30] for cbo3 using water-soluble quinone analogues, UQ-1 and UQ-2. Musser et al.
could not excluded that the observed kinetic properties were due to the high concentrations
of UQ-1 and UQ-2 used in the essays, which resulted in non-ideal solution conditions.
Although the data presented here confirm the substrate inhibition, it can still not be excluded
that the substrate inhibition is due to some non-ideal behaviour of the quinones in the
membrane such as aggregation of ubiquinone or disruption of the lipid bilayer. However, no
indication of non-ideal behaviour was observed and the more likely explanation is that the
enzyme is subjected to substrate inhibition. It is possible that a second ubiquinol binds close
or at the active site (QL) during turn-over, disrupting the catalytic reaction at this site.
However, the fact that the inhibition is specific to ubiquinol (and not ubiquinone) makes this
less likely. An alternative model was previously suggested; at high concentrations of
ubiquinol, the quinone in high affinity ubiquinone site, QH, is replaced by an ubiquinol,
making it impossible for the QH site to be reduced to the semiquinone intermediate that is
required during turnover.[30, 31] The location of the QH site close to the surface of the
enzyme[5, 8] suggest it could be possible that the ubiquinone is replaced. However, the
quinone is known to be tightly bound and not easily removed from the QH site, making it
less likely that replacement can occur at a fast rate. An alternatively explanation is that at
high ubiquinol concentration in the membrane, ubiquinol binds close to the QH site in an a-
specific manner such that the ubiquinone in the QH site is reduced to a ubiquinol. In this
model, the inhibition would also depend on the redox state of the ubiquinone pool or, in
other words, inhibition would only take place when most of the ubiquinol is in the reduced
state.
Inhibitor studies
Two distinct voltammetric behaviours are observed depending on the type of compound
used to inhibit cbo3. We hypothesise this is due to the inhibition of the two active sites in
cbo3; the quinol oxidation site and the oxygen reducing site (with rates k1 and k2,
respectively, see Figure 4). NaCN, which induces a shift in the wave’s midpoints (Figure 3),
binds to the binuclear centre in the active site, thereby directly reducing the oxygen
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reduction reaction (rate k2 in Figure 4). The other inhibitors, HQNO and ZnSO4, have a
distinct response and do not cause a shift in the midpoint of the catalytic wave.
The effect of these inhibitors on the voltammograms can be explained by taking into account
that the total current is dependent on both k1 and k2 with the slowest reaction being the rate
limiting step. The second important feature is that the rate k1 is dependent on the redox state
of the ubiquinone pool, which in turn is dependent on the applied potential. Thus, at high
potential (the onset of the wave), little ubiquinol is reduced and thus k1 is low and rate
limiting. At low potential (the plateau region), all ubiquinol is reduced and the activity is
either limited by k1 or k2. Cyanide inhibits the oxygen reducing site and thus lowers the rate
k2. As a result, by increasing the cyanide concentration, k2 will become rate limiting. The
lower the rate of k2, the higher the potential at which it becomes rate limiting (as the rate k1
is dependent on potential). Increasing cyanide thus changes the shape as well as the
magnitude of the wave.
In contrast, HQNO reduces the rate k1 and if this is done in a truly competitive manner, rate
k1 will still be dependent on the oxidation state of the quinone pool and thus the wave shape
will remain unaltered although the magnitude decreases. HQNO is indeed thought to inhibit
cbo3 competitively by binding at the QL site in the enzyme[32, 33] although kinetic analysis
suggests that HQNO may actually be an uncompetitive[30] or non competitive[34] inhibitor,
possibly also interacting with the QH site. The IC50 value (~21 μM) determined here is
considerably higher than previously determined values (0.3 μM) [18]. We propose that this
difference is due to the different assay conditions used, changing the nature of the quinol
substrate and ‘effective’ quinol and inhibitor concentration in the lipid environment.
Although during the cyclic voltammogram, the concentration of substrate varies,
differentiating between non competitive and uncompetitive inhibition based on the cyclic
voltammetry would only be possible if the quinol oxidation is irreversible (if the reduction
potential of cbo3 is much lower than UQ-10). In contrast, the fact that the midpoint of the
catalytic wave remains unaltered upon addition of HQNO can only be explained if cbo3 is in
redox equilibrium with the quinol/quinone pool in the membrane and the reduction of cbo3
is not significantly different from that of UQ-10. If this was not case, the onset of the
catalytic wave would remain unchanged upon addition of HQNO as in this situation the
enzyme activity during the scan would only be limited by the ubiquinol concentration and
not influenced by ubiquinone (or the ratio of ubiquinol/ubiquinone). Modelling studies
(Supporting Information) indeed confirm that the data can only be simulated if a model is
assumed in which cbo3 is in redox equilibrium with the UQ-10 pool.
Zinc and other selective divalent cations, like cadmium, nickel and cobalt[35, 36] have been
shown to inhibit heme copper oxidases such as cbo3 and cytochrome c oxidase. At low
concentration, the cations are thought to inhibit the enzymes by blocking the release of
protons[25, 36]. The voltammograms after inhibition with HQNO and ZnSO4 showed a very
similar behaviour contrasting that of NaCN. Especially at the intermediate inhibitor
concentrations, both inhibitors induce a double wave effect in the voltammogram. These
results thus confirm that Zn(II) inhibition is not affecting proton uptake to supply protons for
oxygen reduction, but mainly inhibits enzyme reduction by quinol or the coupled release of
protons (from quinol oxidation). This latter observation might be influenced by the
enzyme’s orientation on the surface. If the enzyme is oriented with the N-side towards the
surface, Zn(II) ions can only bind to the P-side, corresponding to the impairment of proton
release as shown for cytochrome c oxidase.[25]
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
A schematic representation of the tBLM used in this work.
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Figure 2.
(Top) Cyclic voltammograms of a tBLM containing cbo3 at increasing UQ-10 coverage
(determined separately using cyclic voltammograms at 1 V/s). Electrode area is ~ 0.25 cm2
(Top, Insert) The UQ-10 coverage (determined using cyclic voltammograms at 1 V/s) as a
function of UQ-10 added to the electrolyte from a DMSO stock solution.
(Bottom) (Closed symbols) Normalised activity of cbo3 as a function of UQ-10 coverage for
three different experiments (squares, triangles and circles). The UQ-10 coverage (bottom
axis) is determined by determination of the UQ-10 peak area from voltammograms
measured at 1 V/s. (Open symbols) Comparison with previously published data[13] in which
UQ-10 is cosolubilised in vesicles prior to tBLM formation and the UQ-10 coverage (top
axis) is determined at 10 mV/s after inhibition of cbo3 with NaCN. The top and bottom axis
have different scales due to observed differences in UQ-10 coverage when determined at 1
V/s and 10 mV/s (see text).
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Figure 3.
(Top) Cyclic voltammograms for cytochrome bo3 inhibited with (NaCN) at 0μM, 5μM,
10μM, 20μM, 30μM and 90μM, (HQNO) at 0μM, 40μM, 60μM, 80μM and 190μM and
(ZnSO4) at 0μM, 25μM, 50μM and 125μM. The QU-10 concentration in the membrane is
between 5 and 10 pmol/cm2. The electrode area is 0.25 cm2 (Middle) Baseline corrected
voltammograms of the data shown in Top. The baseline was taken from the cyclic
voltrammogram measured at the highest concentration of inhibitor. (Middle, insert)
Extracted data for IC50 determination. Error bars are standard deviations determined from at
least three experiments. (Bottom) First derivatives of the data shown in Middle.
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Figure 4.
Schematic representation of the tBLM and the rates that influence the currents measured
with cyclic voltammetry.
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